Xin Lang Cai Jing·2025-11-11 03:03Core Viewpoint - Spring Medical's stock has experienced significant fluctuations, with a year-to-date increase of 115.12% but a recent decline of 2.04% on November 11, 2023, indicating potential volatility in the market [1]. Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [1][2]. - The company's main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [1]. Financial Performance - For the period from January to September 2025, Spring Medical reported a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, which is a 213.21% increase compared to the previous year [2]. - Since its A-share listing, Spring Medical has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Spring Medical increased by 4.12% to 6,164, while the average number of tradable shares per shareholder decreased by 3.95% to 46,906 shares [2]. - Notable new institutional shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed A, holding 2.9585 million shares and 2.8326 million shares, respectively [3].